Gaucher Disease Market Trends, Industry Survey, Overview and Forecast till 2025
Global Gaucher Disease Market is classified on the basis of product type,
type of treatment molecules, route of administration, dosage forms, end users,
and geography. A rare inherited disorder that results from the deficiency of
the enzyme glucoce rebrosidase is known as Gaucher disease. The typical
character of this disease is that there is deposition of fatty substances in
body’s organs and tissues.
The signs and symptoms of Gaucher disease
may differ widely among people. Some of the signs and symptoms of Gaucher
disease include fatigue, enlarged liver and spleen, low platelet and hemoglobin
counts, bone pain and fractures, etc. The diagnosis of Gaucher disease can be
carried out by laboratory testing either by quantifying the level of the enzyme
glucoce rebrosidase or by DNA study of the GBA gene for the four most common
GBA mutations.
Access Gaucher Disease Market Report with TOC @ https://www.millioninsights.com/industry-reports/gaucher-disease-market
There
are mainly three types of Gaucher disease. The mildest and most common type of
Gaucher disease is Type 1. The type 1 disorder is also known as
Nonneuronopathic Gaucher disease and it does not affect the nervous system.
Whereas,
neuronopathic forms of Gaucher disease are Type 2 also called as acute
infantile neuronopathic Gaucher disease and Type 3 also called as chronic
neuronopathic Gaucher disease. These types of disorder affect the central
nervous system and cause severe problems brain damage, seizures, respiratory
problems, poor development, eye movement disorders, enlarged spleen &
liver, bone problems, etc.
Gaucher
Disease is also known as glucosylceramide lipidosis, cerebrosidelipidosis
syndrome, kerasinlipoidosis, glucocerebrosidase deficiency,
kerasinhistiocytosis, glucosylceramide beta-glucosidase deficiency, Gaucher
splenomegaly, glucosylceramidase deficiency, Gaucher syndrome,
glucocerebrosidosis, lipoid histiocytosis (kerasin type), Gaucher's disease,
GD, glucosylcerebrosidelipidosis and kerasinthesaurismosis.
The
factors that propel the growth of the Gaucher Disease Market include increasing
research & development activities and specialfacility for orphan drugs. On
the other hand, there are also factors that may hamper the growth of the market
such asinadequate patient population as it is a rare disease. Gaucher Disease
Market is classified on the basis of product type asenzyme replacement therapy
and substrate reduction therapy.
Gaucher
Disease Market is classified on the basis oftype of treatment molecules as
biologics, small molecules and others. Gaucher Disease Market is classified on
the basis of route of administration asoral, and parenteral. Gaucher Disease
Market is classified on the basis of dosage forms as solid, liquid and others.
Gaucher
Disease Market is classified on the basis of end users as Non-neuronopathic
Gaucher disease and Neuronopathic Gaucher disease.
This report studies the global
Gaucher Disease market, analyzes and researches the Gaucher Disease development
status and forecast in United States, EU, Japan, China, India and Southeast
Asia. This report focuses on the top players in global market, like
•
Sanofi
•
Shire
•
Actelion Pharma
•
Pfizer
• ISU
Pharm
Market segment by Type, the
product can be split into
•
Enzyme Replacement Therapy
•
Substrate Reduction Therapy
Market segment by Application,
Gaucher Disease can be split into
•
Non-Neuronopathic Gaucher Disease
•
Neuronopathic Gaucher Disease
Request a Sample Copy of Gaucher Disease Market Report @ https://www.millioninsights.com/industry-reports/gaucher-disease-market/request-sample
Market segment by Regions/Countries, this report covers
• United States
• EU
• Japan
• China
• India
• Southeast Asia
Comments
Post a Comment